MedTrace Logo

Echinacea-based Supplement Does Not Improve Markers of Performance in Athletes

NCT02134119 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2017-01-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study was three-fold. We wanted to (1) determine if supplementation with an echinacea-based dietary supplement (ECH) would increase several blood parameters that could affect oxygen carrying capacity in the body, (2) determine if ECH would increase VO2max in trained endurance athletes, and (3) examine the effectiveness of two different doses of the ECH on all outcome variables. We hypothesized that supplementation with ECH would increase oxygen carrying capacity (as measured by RBCs, EPO, ferritin, hemoglobin (Hb), and hematocrit (Hct) levels), improve VO2max, and that the maximum dose would be most effective at increasing these outcomes.

Conditions

  • Ineffective Erythropoiesis

Interventions

DIETARY_SUPPLEMENT

Echinacea-based dietary supplement

Echinacea-based dietary supplement given at 8,000mg/day or 16,000 mg/day by mouth

DRUG

Placebo

Sugar pill manufactured to mimic dietary supplement

Sponsors & Collaborators

  • University of Georgia

    lead OTHER

Principal Investigators

  • Jamie A Cooper, Ph.D. · Texas Tech University

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02134119 on ClinicalTrials.gov